References
- Lin S. Y., et al. Pharm. Acta Helv. 1989; 64: 236
- Jonkman J. H.G., et al. “The correlation between “In Vitro” dissolution and “In Vivo”disposition of sustained release theophylline tablets”. Proceeding of the first Europeen Congress of Biopharmaceutics and Pharmacokinetics, J. M. Aiache, J. H. Hirtz. Paris 1981; 182
- Paris L, et al. S. T. P. Pharma 1985; 1: 412
- Bachiler M. C.M., et al. Farm. Clíni. 1986; 3: 75
- Bafalluy M. A.M., et al. Farm. Clín. 1984; 1: 673
- Fraile J. M.M. Farm. Clíni. 1985; 2: 270
- Li Wan Po A., et al. Int. J. Pharm. 1990; 66: 111
- Upton R. A., et al. J. Pharmacokinet. Biopharm. 1980; 8: 131
- Upton R. A., et al. J. Pharmacokinet. Biopharm. 1980; 8: 151
- Chung B. H., et al. J. Pharm. Sci. 1987; 76: 784
- Hussein, et al. Pharm. Res. 1990; 7: 1167
- Otero L., et al. “Theophylline Spectral curve variations versus pH”. 29th International Congress of Pharmaceutical Sciences. F.I.P., London 1969; C1
- Cotta G., et al. Pharm. Res. 1969; 24: 766, II Farmaco, Ed. Pr.
- Khan K. A. J. Pharm. Pharmac 1975; 22: 48
- Rameis H., et al. Z. Gastroenterol. 1991; 29: 1